Get started
Work

Figure S2 from Efficacy and Safety of Dabrafenib in Pediatric Patients with BRAF V600 Mutation–Positive Relapsed or Refractory Low-Grade Glioma: Results from a Phase I/IIa Study

Year: 2023
Type: other
Abstract: Investigator-assessed percent change at maximum reduction from baseline in tumor measurement per RANO criteria
DOI: 10.1158/1078-0432.22475958
Authors: Darren R. Hargrave, Eric Bouffet, Uri Tabori, Alberto Broniscer, Kenneth J. Cohen, Jordan R. Hansford, Birgit Geoerger, Pooja Hingorani, Ira J. Dunkel, Mark W. Russo, Lillian Tseng, Kohinoor Dasgupta, Eduard Gasal, James A. Whitlock, Mark W. Kieran
Language: English
Subfield: Genetics
Field: Medicine
Open Access status: gold
OpenAlex ID: W4361969816
Cites:
Cited by:
Related to: 10